Liver transplant for cirrhosis with early liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have cirrhosis (liver scarring) and liver cancer caused by hepatitis B.
- Your liver function is stable enough (Child-Pugh class A or B).
- Your liver tumors meet the 'up to seven' criteria – the total of the largest tumor size plus the number of tumors is 7 or less.
- You are generally able to take care of yourself (performance status 0 or 1).
- You do not have cancer spread outside the liver, major blood vessel invasion, or severe complications like hepatic encephalopathy or pulmonary hypertension.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called SALT for people with liver cirrhosis caused by hepatitis B. It aims to see if it can improve liver function and reduce complications.
This study is looking at whether a liver transplant can help people who have liver cancer that has spread into the bile ducts, which are the tubes that carry bile from the liver. We want to see if this surgery is safe and how well it works for these patients.
This trial is testing a new approach for people whose colorectal cancer has spread to the liver and cannot be removed by surgery. The treatment involves a liver transplant, so it is for patients whose tumors are stable or improving after chemotherapy and have not spread beyond the liver (or have only a few removable lung spots). It aims to improve outcomes for patients with limited options.
This study combines two surgeries—first removing part of the tumor, then a liver transplant—for patients with advanced liver cancer or liver failure. It aims to offer a chance for cure when standard treatments are not possible.
This trial tests if a liver transplant can help people with a certain type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. Before the transplant, you would receive radiation therapy (SIRT) and chemotherapy to shrink the tumor.
This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.